Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of CTX-4430 (acebilustat) in Adult Patients with Cystic Fibrosis
2015-002677-38Phase 2Completed
- Sponsor
- Celtaxsys, Inc.
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Acebilustat once-daily with Placebo once-daily (2 arms). Primary endpoint: Change in FEV1 percent predicted from baseline to Week 48. Started Oct 2015; status: completed.
02
Drugs
acebilustat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2015-002677-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002677-38.